Clean Yield Group boosted its stake in AFLAC Incorporated (NYSE:AFL) by 71.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,911 shares of the financial services provider’s stock after purchasing an additional 2,884 shares during the quarter. Clean Yield Group’s holdings in AFLAC were worth $366,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Lenox Wealth Advisors LLC bought a new stake in shares of AFLAC in the third quarter worth about $25,000. KCS Wealth Advisory bought a new stake in shares of AFLAC in the third quarter worth about $27,000. North Star Investment Management Corp. bought a new stake in shares of AFLAC in the third quarter worth about $31,000. Quest Capital Management Inc. ADV bought a new stake in shares of AFLAC in the third quarter worth about $47,000. Finally, Bourgeon Capital Management LLC bought a new stake in shares of AFLAC in the third quarter worth about $56,000. Institutional investors and hedge funds own 62.98% of the company’s stock.
In related news, VP Richard Williams, Jr. sold 1,900 shares of the stock in a transaction that occurred on Thursday, December 5th. The stock was sold at an average price of $52.99, for a total transaction of $100,681.00. Also, Director Karole Lloyd purchased 1,000 shares of AFLAC stock in a transaction that occurred on Thursday, November 7th. The shares were bought at an average cost of $54.08 per share, with a total value of $54,080.00. Following the completion of the transaction, the director now directly owns 28,181 shares of the company’s stock, valued at approximately $1,524,028.48. The disclosure for this purchase can be found here. 1.30% of the stock is owned by corporate insiders.
AFL stock opened at $53.42 on Friday. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.05 and a quick ratio of 0.05. The stock has a market capitalization of $39.21 billion, a P/E ratio of 12.84, a P/E/G ratio of 2.80 and a beta of 0.70. The business has a 50-day moving average of $52.93 and a 200-day moving average of $52.99. AFLAC Incorporated has a fifty-two week low of $46.96 and a fifty-two week high of $57.18.
AFLAC (NYSE:AFL) last posted its quarterly earnings data on Thursday, October 24th. The financial services provider reported $1.16 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.09. The company had revenue of $5.54 billion during the quarter, compared to analysts’ expectations of $5.52 billion. AFLAC had a return on equity of 12.45% and a net margin of 13.96%. AFLAC’s revenue for the quarter was down .7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.03 earnings per share. Equities analysts expect that AFLAC Incorporated will post 4.42 EPS for the current year.
Several research analysts have recently weighed in on the company. JPMorgan Chase & Co. cut AFLAC from an “overweight” rating to a “neutral” rating in a research report on Thursday, January 2nd. UBS Group upped their price objective on AFLAC from $51.00 to $53.00 and gave the stock a “neutral” rating in a research report on Thursday, October 10th. Raymond James reduced their price objective on AFLAC from $62.00 to $60.00 and set a “buy” rating for the company in a research report on Thursday, December 5th. Finally, Bank of America set a $55.00 price objective on AFLAC and gave the stock a “hold” rating in a research report on Friday, October 25th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. AFLAC presently has a consensus rating of “Hold” and a consensus target price of $53.82.
AFLAC Company Profile
Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
See Also: Market Indexes
Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.